You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Patent: 9,365,632


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,365,632
Title:Exendin-4 derivatives as dual GLP1/glucagon agonists
Abstract: The present invention relates to exendin-4 derivatives and their medical use, for example in the treatment of disorders of the metabolic syndrome, including diabetes and obesity, as well as reduction of excess food intake.
Inventor(s): Haack; Torsten (Frankfurt am Main, DE), Wagner; Michael (Frankfurt am Main, DE), Henkel; Bernd (Frankfurt am Main, DE), Stengelin; Siegfried (Frankfurt am Main, DE), Evers; Andreas (Frankfurt am Main, DE), Bossart; Martin (Frankfurt am Main, DE)
Assignee: SANOFI (Paris, FR)
Application Number:14/049,597
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Understanding the Scope and Claims of United States Patent 9,365,632: A Comprehensive Analysis

Introduction

Patent analysis is a crucial step in understanding the intellectual property landscape, particularly for businesses and inventors looking to protect their innovations. This article will delve into the details of United States Patent 9,365,632, exploring its scope, claims, and the broader patent landscape it operates within.

Patent Overview

United States Patent 9,365,632, hereafter referred to as the '632 patent, is a utility patent granted by the United States Patent and Trademark Office (USPTO). To analyze this patent, we need to consider several key aspects, including the invention's background, summary, detailed description, and the claims.

Background of the Invention

The background section of the patent provides context about the existing technology and the problems it addresses. This section is crucial for understanding the motivation behind the invention and how it improves upon prior art. For the '632 patent, this would involve a review of the relevant technological field and any preceding inventions or solutions that the patent aims to enhance or replace[4].

Summary of the Invention

The summary section offers a concise overview of the invention, highlighting its key features and how it operates. This section is essential for quickly grasping the essence of the patent without delving into the detailed description. It typically includes the main components, their interactions, and the benefits of the invention[4].

Detailed Description of the Invention

This section provides a thorough explanation of the invention, including drawings, diagrams, and detailed descriptions of each component. It must be sufficient to enable a person with ordinary skill in the relevant art to make and use the invention without undue experimentation. This is a critical requirement under U.S. patent law[5].

Claims of the Patent

The claims are the most important part of a patent, as they define the scope of the invention and what is protected by the patent. Claims must be clear, concise, and supported by the description. There are two main types of claims: independent claims, which stand alone, and dependent claims, which refer back to and further limit an independent claim[4].

Independent Claims

Independent claims define the broadest scope of the invention. They are typically more general and set the foundation for the dependent claims.

Dependent Claims

Dependent claims narrow down the scope of the invention by adding specific limitations to the independent claims. These claims are often more detailed and provide additional protection by covering various embodiments of the invention.

Patent Scope and Landscape

Patent Scope

The scope of a patent is determined by its claims. The broader the claims, the wider the scope of protection. However, broader claims are also more likely to be challenged for obviousness or lack of novelty. The '632 patent's scope would be analyzed by examining its claims in the context of prior art and existing patents in the same technological field[3].

Patent Landscape

The patent landscape includes all relevant patents and applications in the same or related technological fields. Analyzing this landscape helps in understanding the competitive environment, potential infringement risks, and opportunities for further innovation. Tools like the USPTO's Patent Claims Research Dataset can be used to gather detailed information on claims and their dependency relationships, providing insights into the patent scope and landscape[3].

Determining Inventorship

Correctly identifying the inventors is crucial for the validity and enforceability of a patent. U.S. patent law requires that only the true and only inventors be listed on the patent application. This involves a two-step process: conception of the idea and reduction of the idea to practice. Incorrect or incomplete identification of inventors can lead to challenges and potential invalidation of the patent[2].

Obviousness-Type Double Patenting (ODP)

ODP is a doctrine that prevents the same inventor or assignee from obtaining multiple patents for the same invention or obvious variations thereof. This is particularly relevant when dealing with continuation-in-part patents or patents that claim priority from the same application. The '632 patent would need to be analyzed to ensure it does not infringe on ODP rules, especially if it is part of a larger patent family[1].

Commercial and Market Implications

The commercial viability of the '632 patent depends on several factors, including its novelty, non-obviousness, and the ability to enforce it. The patent's market potential is also influenced by the presence of commercial partners and the costs associated with patent prosecution and maintenance. A thorough analysis would involve assessing the patent's enforceability, potential for design-around, and the overall intellectual property strategy[5].

Key Takeaways

  • Claims Analysis: The claims of the '632 patent define its scope and protection.
  • Patent Scope: Understanding the patent's scope is crucial for determining its breadth of protection.
  • Patent Landscape: Analyzing the patent landscape helps in identifying competitive risks and opportunities.
  • Inventorship: Correct identification of inventors is essential for the patent's validity.
  • ODP: Ensuring compliance with ODP rules is vital to avoid invalidation.
  • Commercial Viability: Assessing the patent's commercial potential involves evaluating its enforceability and market strategy.

FAQs

What is the primary purpose of the claims in a patent?

The primary purpose of the claims in a patent is to define the scope of the invention and what is protected by the patent.

How is the scope of a patent determined?

The scope of a patent is determined by its claims, with broader claims providing wider protection but also being more susceptible to challenges.

What is obviousness-type double patenting (ODP)?

ODP is a doctrine that prevents the same inventor or assignee from obtaining multiple patents for the same invention or obvious variations thereof.

Why is correct inventorship important in patent applications?

Correct inventorship is crucial for the validity and enforceability of a patent, as incorrect or incomplete identification can lead to challenges and potential invalidation.

What are the typical steps in the patenting process after filing a provisional patent application?

After filing a provisional patent application, one has a year to decide whether to continue with a non-provisional patent application. If proceeding, a patent examiner reviews the application for patentability, which may involve arguments and amended claims before a final decision is made[5].

Sources

  1. In re Cellect - United States Court of Appeals for the Federal Circuit, August 28, 2023.
  2. Determining Inventorship for US Patent Applications - Oregon State University.
  3. Patent Claims Research Dataset - USPTO.
  4. Patent Law in the United States - BitLaw.
  5. Intellectual Property Protection - KU Office of Research.

More… ↓

⤷  Subscribe

Details for Patent 9,365,632

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Eli Lilly And Company HUMULIN R U-100 insulin human Injection 018780 October 28, 1982 9,365,632 2032-10-09
Eli Lilly And Company HUMULIN R U-500 insulin human Injection 018780 December 29, 2015 9,365,632 2032-10-09
Eli Lilly And Company HUMULIN R U-100 insulin human Injection 018780 August 06, 1998 9,365,632 2032-10-09
Eli Lilly And Company HUMULIN R U-500 insulin human Injection 018780 March 31, 1994 9,365,632 2032-10-09
Eli Lilly And Company HUMULIN R U-100 insulin human Injection 018780 May 25, 2018 9,365,632 2032-10-09
Novo Nordisk Inc. NOVOLIN R insulin human Injection 019938 June 25, 1991 9,365,632 2032-10-09
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.